Results 21 to 30 of about 4,571 (215)

A patient with Pfeifer-Weber-Christian Disease - Successful Therapy with Cyclosporin A: case report [PDF]

, 2010
Background: Pfeifer-Weber-Christian disease (PWCD) is a rare inflammatory disorder of the subcutaneous fatty tissue. The diagnosis and therapy of this rare type of panniculitis is still controversial and will be discussed in this article.
Georg Pongratz, Boris Ehrenstein, Wolfgang Hartung, Jürgen Schölmerich, Martin Fleck, P Michael, L Requena, JW White Jr, V Pfeifer, FP Weber, HA Christian, KM Niemi, KC Smith, T Iwasaki, M Kovacs, M Hinata, N Miyasaka, S Viravan, G Royle, K Usuki, P Entzian, BE Ostrov, AC Allison   +22 more
core   +1 more source

A Case of Facial Lipoatrophy Secondary to Lupus Profundus Managed with Lipofilling Technique [PDF]

, 2012
Facial lipoatrophy is one of the most difficult complication in the patients with lupus profundus. In this paper, we present a case of a 55-year-old woman affected by lupus profundus, with a grade V lipoatrophy, treated with lipofilling technique.
Federico Tamborini, Francesca Maggiulli, Igor Pellegatta, Luigi Valdatta, Mario Cherubino   +4 more
core   +2 more sources

Necrotizing Panniculitis as an Uncommon Manifestation of Acute Pancreatitis [PDF]

, 2017
Pancreatic panniculitis is a rare disorder affecting 2–3% of patients with pancreatic disease. The findings are characterized by tender, erythematous, subcutaneous nodules which may undergo spontaneous ulceration with discharge of brownish and viscous ...
Amaradio, Maria Domenica, Bellinvia, Salvatore, Bruno, Cosimo Marcello, Cantone, Damiano, Polosa, Riccardo, Pricoco, Gabriele Sebastiano   +5 more
core   +3 more sources

Subcutaneous panniculitis‐like T‐cell lymphoma in a young girl presenting with periorbital edema and fever: A case report

Clinical Case Reports, 2022
Subcutaneous panniculitis‐like T‐cell lymphoma is a rare and highly malignant extra‐nodal lymphoma. It has a wide range of clinical presentations (such as periorbital swelling as in our case) and should be considered in the differential diagnosis of ...
Seyed Mohamad Kazem Nourbakhsh, Mohammad Bahadoram, Farid Kosari, Mehrdad Jafari, Nahid Aslani, Shakiba Hassanzadeh   +5 more
doaj   +1 more source

An unusual location of gouty panniculitis: A case report. [PDF]

, 2017
Gouty panniculitis, characterised by the deposition of monosodium urate crystals in subcutaneous tissue, is a rare clinical manifestation of gout. The case of a 67-year-old man is reported, who presented an erythematous nodule on the upper part of the ...
Brunel, C., Demartines, N., Fournier, P., Gié, O., Joliat, G.R., Martin, D.   +5 more
core   +1 more source

Unusual Presentation of Subcutaneous Panniculitis-Like T-Cell Lymphoma. [PDF]

Clin Case Rep
ABSTRACT Subcutaneous panniculitis‐like T‐cell lymphoma (SPTCL) is a rare variant of primary cutaneous T‐cell lymphoma primarily affecting subcutaneous adipose tissue and mimicking lobular panniculitis. It often presents with erythematous subcutaneous nodules or plaques, and diagnosis can be challenging due to its diverse clinical manifestations.
Alkallabi M, Alotaibi H, Nagshabandi KN, Bin Idris R, Abualola AH, Alshehri NA, Alhumidi A.   +6 more
europepmc   +2 more sources

Cutaneous adverse events associated with disease-modifying treatment in multiple sclerosis: A systematic review [PDF]

, 2012
Glatiramer acetate and interferon-beta are approved first-line disease-modifying treatments (DMTs) for multiple sclerosis (MS). DMTs can be associated with cutaneous adverse events, which may influence treatment adherence and patient quality of life.
Alava C, Batista J, Bayerl C, Debat Zoguereh D, Devonshire V, Dimov V, Gaudez C, Heinzerling L, Kaiser C, Madray M, Nakamura Y, Navne JE, Neutralizing antibodies during treatment of multiple sclerosis with interferon beta-1b: experience during the first three years, Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis, Poulin F, Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis, Rio J, Sanchez-Lopez J, Weinberg JM, Yang CH, Ziegler VR   +20 more
core   +1 more source

Panniculitis in childhood-onset systemic lupus erythematosus: a multicentric cohort study

Advances in Rheumatology, 2019
Objective To evaluate prevalence, clinical manifestations, laboratory abnormalities, treatment and outcome in a multicenter cohort of childhood-onset systemic lupus erythematosus (cSLE) patients with and without panniculitis.
Mônica Verdier, Pedro Anuardo, Natali Weniger Spelling Gormezano, Ricardo Romiti, Lucia Maria Arruda Campos, Nadia Emi Aikawa, Rosa Maria Rodrigues Pereira, Maria Teresa Terreri, Claudia Saad Magalhães, Juliana C. O. A. Ferreira, Marco Felipe Castro Silva, Mariana Ferriani, Ana Paula Sakamoto, Virginia Paes Leme Ferriani, Maraísa Centeville, Juliana Sato, Maria Carolina Santos, Eloisa Bonfá, Clovis Artur Silva   +18 more
doaj   +1 more source

Case series of anifrolumab for treatment of cutaneous lupus erythematosus and lupus-related mucocutaneous manifestations in patients with SLE

Lupus Science and Medicine, 2023
Objective To assess the efficacy of anifrolumab, a type-1 interferon receptor subunit-1 monoclonal antibody, in treating refractory cutaneous lupus erythematosus (CLE) and lupus non-specific mucocutaneous manifestations in patients with systemic lupus ...
Jun Kang, Aaron Bao
doaj   +1 more source

Type I interferonopathies in pediatric rheumatology. [PDF]

, 2016
Defective regulation of type I interferon response is associated with severe inflammatory phenotypes and autoimmunity. Type I interferonopathies are a clinically heterogenic group of Mendelian diseases with a constitutive activation of this pathway that ...
Candotti, F., Caorsi, R., Gattorno, M., Picco, P., Volpi, S.   +4 more
core   +2 more sources